logo

For the Inventor, By the Inventor

Robbinsville, NJ, United States of America

Alfred Lee

This inventor holds 5 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Merck Sharp + Dohme Corp., Merck Sharp + Dohme B.v., Werthenstein Biopharma Gmbh. Active years: 2018-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alfred Lee. Retrieved from https://idiyas.com/inventor/alfred-lee-pi77c2ib

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal5 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
silverMedal1 out of 55 
 
Merck Sharp + Dohme B.v.
 patents
bronzeMedal1 out of 2 
 
Werthenstein Biopharma Gmbh
 patents
where one patent can have more than one assignee

Years Active: 2018-2023

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents
1. 11584724 - Process for synthesis of a phenoxy diaminopyrimidine compound (2023-02-21),
2. 11292810 - Inclusion complexes of an HCV NS5B inhibitor and uses thereof (2022-04-05),
3. 10301281 - Crystal forms of a CCR5 antagonist (2019-05-28),
4. 10167298 - Pseudopolymorphs of an HCV NS5A inhibitor and uses thereof (2019-01-01),
5. 10058544 - (S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations (2018-08-28),

Title: Innovations and Contributions of Inventor Alfred Lee

Introduction

Alfred Lee is a notable inventor based in Robbinsville, NJ (US), recognized for his significant contributions to the field of chemistry and pharmaceuticals. With a total of five patents to his name, he has made strides in developing novel processes and compounds that have potential applications in treating various health conditions.

Latest Patents

One of Alfred Lee's latest patents is a process for the synthesis of a phenoxy diaminopyrimidine compound. This patent discloses a novel method for preparing Compound A free base, specifically 5-((2,4-diaminopyrimidin-5-yl)oxy)-4-iso-propyl-2-methoxybenzenesulfonamide, along with a citrate salt of Compound A. The process boasts simplified chemistry and achieves a high overall yield, with yields exceeding 50% and even 60% in certain embodiments. Additionally, he has developed inclusion complexes of an HCV NS5B inhibitor, which are compositions that utilize Compound A for treating or preventing HCV infection in patients.

Career Highlights

Throughout his career, Alfred Lee has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and Werthenstein Biopharma GmbH. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Alfred has collaborated with notable professionals in his field, including Michael J. McNevin and Deepak Bahl. These collaborations have likely enhanced his research and development efforts, leading to impactful inventions.

Conclusion

Alfred Lee's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…